JUN 05, 2018 11:12 PM PDT

Efficacy of 'Ribavirin Treatment' in Hemorrhagic Fever

WRITTEN BY: Nouran Amin

Up to 40% of people die from a viral hemorrhagic disease and until now physicians cannot agree if the only treatment available, an antiviral drug by the name of Ribavirin, is actually effective in treatment.

Chemical Structure of Ribavirin. Image via Wikipedia

Now, in a Cochrane Review, a group of researchers at the London School of Tropical Medicine (LTSM) along with colleagues in London, The Philippines and in Greece, have attempted to evaluate the efficacy of treating Crimean Congo hemorrhagic fever (CCHF).

 

Spread by the bite of an insect (or through contact of infected animal tissue), Crimean Congo hemorrhagic fever is becoming more common in Turkey, Eastern Europe and the Eastern Mediterranean. Physicians treating infected individuals in a hospital setting will seek intravenous fluids, blood and appropriate nursing care. The Ribavrin debate has become common among health care providers treating CCHF with strong supporters on one hand, and those fighting to stop its use on the other hand.

The review investigators discovered that one trial involving 136 participants, and some observational comparative studies involving 612 participants. However, the overall analysis of these studies has not provided a definite answer on the effectiveness of Ribavirin. The studies were investigated to be primarily biased. Even though a small number of individuals receiving Ribavirin treatment died, the apparent effect could be due to the drug, or equally because individuals that were receiving the drug could have also been less sick, or been recipients of top-notch medical care earlier in the CCHF disease progression.

 

Lead investigator, Dr. Samuel Johnson, explains that "Some doctors advocate giving ribavirin, and state that not to give it is even unethical. The problem is that the studies claiming to demonstrate benefit from the drug are designed in such a way we cannot separate the effect of the drug from other factors, and thus we do not know if ribavirin is effective at all."

 

The review paper urges the need for reliable research in a randomized control trial in order to test the efficacy of Ribavirin. "The irony is that the strong beliefs and the widespread use of the drug may make it difficult to actually carry out the research needed" states Dr. Johnson. "What we need to know is whether it works, when it works, and how good it is."

Sources: Cochrane Database of Systematic Reviews, Science Daily

 

 

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUN 29, 2021
Technology
Can Digital Simulations Replace Real People in Clinical Trials? Maybe
JUN 29, 2021
Can Digital Simulations Replace Real People in Clinical Trials? Maybe
Clinical trials are essential to the development of new drugs and medicines, and they offer new insights every day about ...
JUL 05, 2021
Neuroscience
People with Autism More Likely to Self-Medicate with Recreational Drugs
JUL 05, 2021
People with Autism More Likely to Self-Medicate with Recreational Drugs
Researchers from the University of Cambridge have found that people with autism are more likely than people without the ...
AUG 02, 2021
Microbiology
The Unique Microbiomes of Long-Lived People
AUG 02, 2021
The Unique Microbiomes of Long-Lived People
What's the secret of people that live a long life? The answer may be complex but for some, it could include the microbio ...
AUG 21, 2021
Drug Discovery & Development
Schools of Fish Inspire 'Microswimmers' that Could Revolutionize Drug Delivery
AUG 21, 2021
Schools of Fish Inspire 'Microswimmers' that Could Revolutionize Drug Delivery
When 'microswimmers'- microscopic objects that can move in liquid environments- move in the same direction insid ...
AUG 25, 2021
Chemistry & Physics
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
AUG 25, 2021
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
A new study from the University of Huddersfield shows promising breakthroughs on the use of self-assembling molecules as ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
Loading Comments...